Intrinsiqq
LifeVantage Corporation logo

LifeVantage Corporation Quality Score

LFVN

⊜ Compare
Quality73

Valuation remains strong (avg 90/100), but growth is pulling the composite down (avg 50/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
90/100
14.9x

Under 20x, reasonable relative to earnings

Cash Flow Multiple
90/100
11.2x

Under 20x cash flow, well covered

Revenue Growth
0/100
-5.1%

Below 2%, essentially flat

Cash Flow Growth
100/100
21.0%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
60/100
1.1%

Mild dilution under 2%

Margin Trend
90/100
+1.3pp

Expanded 1–3pp, steady progress

Capital Structure
100/100
-$5M

Net cash position, no leverage concern

2023
$22.0M
$13.0M
2024
$17.0M
$14.0M
2025
$20.0M
$12.0M
2026
$15.0M
$10.0M
CashDebt
Return on Capital
60/100
11.4%

10–15%, respectable returns

Customize WeightsPremiumUpgrade

LifeVantage (LFVN) quality: score, margins and returns

LifeVantage (LFVN) scores 73/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on 3.3% operating margins and 11.4% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is LifeVantage (LFVN) a high-quality business?+

LifeVantage scores 73 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 3.3% operating margin and a 11.4% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does LifeVantage's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from LFVN's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where LifeVantage scores well and where it falls behind.

What is LifeVantage's return on invested capital (ROIC)?+

LifeVantage earns about 11.4% on its invested capital, which is solid. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to LFVN's margins and growth on this scorecard to judge durability.

How profitable is LifeVantage?+

LifeVantage runs an operating margin of about 3.3% and a net margin of about 2.8%. Revenue has grown at roughly -3.7% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 26 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 3 Oct 2026. How this is calculated.

Fiscal year ends Jun. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Pharmaceutical Preparations · Pick stocks to compare with LFVN

CompareIntrinsic value
MGNXMacrogenics Inc.
$2.31-0.86%36
ABUSArbutus Biopharma Corporation
$4.06+4.64%60
AMRNAmarin Corp PLC\Uk
$12.25+1.66%46
CYRXCryoport Inc.
$16.70+1.52%13
URGNUrogen Pharma Ltd.
$28.71-16.54%30
SLNOSoleno Therapeutics Inc
No recent price25
NUVBNuvation Bio Inc.
$4.73+0.85%10
DAWNDay One Biopharmaceuticals, Inc.
No recent price10

Held by ETFs

LFVN is in 5 US ETFs. The largest of them, with LFVN's weight in each:

Spot a number that looks wrong? Check it in LFVN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LFVN

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.